Skip to main content

Donation Procedure: Collection Lesion, Fibrinopeptide A, and Factor VIII

  • Chapter
Plasma Fractionation and Blood Transfusion

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 13))

Abstract

Following the work of Pflugshaupt (1) a number of groups, including ourselves have re-investigated the effects of donation procedures on the quality of plasma destined for preparation of factor VIII concentrates. The Swiss group argued that thrombin formation in donated blood might have two adverse effects on the quality of plasma; firstly degradation of factor VIII yielding a more labile product, and secondly generation of fibrin resulting in a less soluble product, if this protein forms part of the final factor VIII concentrate. Using fibrinopeptide A (FpA) levels as a measure of the presence of thrombin, they confirmed that plasma containing more than 50 ng/ml FpA resulted in a poorly soluble and labile product when the factor concentrate was made by their technique. It was also shown that an improved donation procedure could reduce plasma FpA levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pfugshaupt R, Kurt G. FpA content — a criterion of quality for plasma factor VIII source. Vox Sang 1983;45:224–32.

    Article  Google Scholar 

  2. Nossel HL, Yudelmann I, Canfield RE, et al. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974;54:43–53.

    Article  PubMed  CAS  Google Scholar 

  3. Carlebjork G, Blomback M, Akerblom O. Improvement of plasma quality as raw material for factor VIII concentrates: storage of whole blood and plasma and interindividual plasma levels of fib rinopep tide A. Vox Sang 1983;45:233–42.

    Article  PubMed  CAS  Google Scholar 

  4. Blomback M, Chmielewska J, Netre C, Akerblom O. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma. Vox Sang 1984;47:335–42.

    Article  Google Scholar 

  5. Prowse CV, Bessos H, Farrugia A, Smith A, Gabra J. Donation procedure, fib rinopep tide A and factor VIII. Vox Sang 1984;46:55–7.

    Article  PubMed  CAS  Google Scholar 

  6. Walter CW. Invention and development of the blood bag. Vox Sang 1984;47:318–24.

    Article  PubMed  CAS  Google Scholar 

  7. Kasper CK, Myhre BA, McDonald JD, Nakasako Y, Feinstein DI. Determinants of factor VIII recovery in cryoprecipitate. Transfusion 1975;15:312–22.

    Article  PubMed  CAS  Google Scholar 

  8. Torma E, Myllyla G. Parameters affecting the fractionation of factor VIII:C activity in production of very high purity AHF concentrate. Scan J Haematol 1984;33(Suppl 40): 123–6.

    Article  Google Scholar 

  9. Vermeer C, Soute BAM, Ates G, Hellings JA, Brummelhuis HGJ. Contributions to the optimal use of human blood: VIII: Stability of blood coagulation factor VIII during collection and storage of whole blood and plasma. Vox Sang;31(Suppl l):55–67.

    Google Scholar 

  10. Weiss HJ. A study of the cation and pH-dependant stability of factors V and VIII in plasma. Thromb Diath Haemorrh 1965;14:32–51.

    PubMed  CAS  Google Scholar 

  11. Rock GA, Cruickshank WH, Tackaberry ES, Palmer DS. Improved yields of factor VIII from heparinised plasma. Vox Sang 1979;36:294–300.

    Article  PubMed  CAS  Google Scholar 

  12. Smit Sibinga CTh, Das PC. Heparin and factor VIII. Scand J Haematol 1984;33(Suppl 40):111–26.

    Article  Google Scholar 

  13. Mikaelsson ME, Forsman N, Oswaldsson UM. Human Factor VIII: a calcium-linked protein complex. Blood 1983;62:1006–15.

    PubMed  CAS  Google Scholar 

  14. Smith JK qu in Penny AF. Anticoagulation in cell separation procedures. Apheresis Bulletin 1983;1:164–71.

    Google Scholar 

  15. Margolis J, Gallovich CM, Rhoades P. A process for preparation of ’high purity1 factor VIII by controlled pore glass treatment. Vox Sang 1984;46:341–8.

    Article  PubMed  CAS  Google Scholar 

  16. Loutit JF. Factors influencing the preservation of stored red cells. J Pathol 1945;57:325–35.

    Article  CAS  Google Scholar 

  17. Mishler JM, Darley JH, Haworth C, Mollison PL. Viability of red cells stored in diminished concentration of citrate. Br J Haematol 1979;43:63–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Prowse, C.V. (1985). Donation Procedure: Collection Lesion, Fibrinopeptide A, and Factor VIII. In: Smit Sibinga, C.T., Das, P.C., Seidl, S. (eds) Plasma Fractionation and Blood Transfusion. Developments in Hematology and Immunology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2631-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2631-1_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9644-7

  • Online ISBN: 978-1-4613-2631-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics